C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study
The Lancet - Early Online Publication, 02/07/2011
Evidence from this large–scale randomised trial does not lend support to the hypothesis that baseline C–reactive protein (CRP) concentration modifies the vascular benefits of statin therapy materially.



